Search results
Results from the WOW.Com Content Network
It was established in 1949 as Electroencephalography and Clinical Neurophysiology and obtained its current title in 1999. The journal covers all aspects of neurophysiology, especially as relating to the pathophysiology underlying diseases of the central and peripheral nervous system.
Ear-EEG is a method for measuring dynamics of brain activity through the minute voltage changes observable on the skin, typically by placing electrodes on the scalp. In ear-EEG, the electrodes are exclusively placed in or around the outer ear, resulting in both a much greater invisibility and wearer mobility compared to full scalp electroencephalography (EEG), but also significantly reduced ...
Electroencephalography (EEG) [1] is a method to record an electrogram of the spontaneous electrical activity of the brain. The biosignals detected by EEG have been shown to represent the postsynaptic potentials of pyramidal neurons in the neocortex and allocortex . [ 2 ]
EEG analysis is exploiting mathematical signal analysis methods and computer technology to extract information from electroencephalography (EEG) signals. The targets of EEG analysis are to help researchers gain a better understanding of the brain; assist physicians in diagnosis and treatment choices; and to boost brain-computer interface (BCI) technology.
While these journals still did not receive an impact factor until the next year, they did contribute citations to the calculation of other journals' impact factors. [ 4 ] [ 5 ] In July 2022, Clarivate announced that journals in the ESCI obtain an impact factor effective from JCR Year 2022 first released in June 2023.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
Signal Transduction and Targeted Therapy is a multidisciplinary peer-reviewed open access scientific journal covering biomedical research with a particular focus on signal transduction and its application to the drug development process. It was established in 2016 and is published by Nature Research.
The journal was edited by John Newsom-Davis from 1997 to 2004, [3] Alastair Compston (Cambridge University) until 2013, and Dimitri Kullmann (UCL) until 2021. The current editor-in-chief is Masud Husain (University of Oxford). According to the Journal Citation Reports, the journal has a 2022 impact factor of 14.5. [4]